Phase II Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy (No Prior Transplant)
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Bortezomib (Primary) ; Cisplatin (Primary) ; Cyclophosphamide (Primary) ; Dexamethasone (Primary) ; Doxorubicin (Primary) ; Etoposide (Primary) ; Melphalan (Primary) ; Thalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 18 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
- 18 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
- 07 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Mar 2017 as per ClinicalTrials.gov record.